Hydroxyurea [clinicaltrials_resource:f82e4c9f89a991c5db967faf0b91fad2]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) [clinicaltrials:NCT00000586]Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG) [clinicaltrials:NCT00000602]A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [clinicaltrials:NCT00000916]A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible [clinicaltrials:NCT00000939]The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients [clinicaltrials:NCT00001074]Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia [clinicaltrials:NCT00001197]Combination Drug Treatment of Pediatric HIV Infection [clinicaltrials:NCT00001818]Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) [clinicaltrials:NCT00001958]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [clinicaltrials:NCT00002176]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [clinicaltrials:NCT00002177]A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients [clinicaltrials:NCT00002230]A Study of MKC-442 in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002412]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002420]Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults [clinicaltrials:NCT00002427]Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002869]Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer [clinicaltrials:NCT00002887]Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS [clinicaltrials:NCT00002940]clinicaltrials:NCT00002951Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00003172]clinicaltrials:NCT00003590Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx [clinicaltrials:NCT00004094]Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes [clinicaltrials:NCT00004404]Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia [clinicaltrials:NCT00004492]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer [clinicaltrials:NCT00004901]clinicaltrials:NCT00004933Safety and Effectiveness of a Combination Anti-HIV Drug Treatment [clinicaltrials:NCT00005018]Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma [clinicaltrials:NCT00006119]Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection [clinicaltrials:NCT00006339]clinicaltrials:NCT00006400Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy [clinicaltrials:NCT00008866]Radiation Therapy in Treating Patients With Glioblastoma [clinicaltrials:NCT00019058]Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [clinicaltrials:NCT00019474]Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00023959]A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. [clinicaltrials:NCT00040677]Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia [clinicaltrials:NCT00056433]clinicaltrials:NCT00122980clinicaltrials:NCT00143572clinicaltrials:NCT00154375clinicaltrials:NCT00175838
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Hydroxyurea [clinicaltrials_resource:f82e4c9f89a991c5db967faf0b91fad2]
Bio2RDF identifier
f82e4c9f89a991c5db967faf0b91fad2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f82e4c9f89a991c5db967faf0b91fad2
identifier
clinicaltrials_resource:f82e4c9f89a991c5db967faf0b91fad2
title
Hydroxyurea
@en
type
label
Hydroxyurea [clinicaltrials_resource:f82e4c9f89a991c5db967faf0b91fad2]
@en